J. Alavi

发表

Positron emission tomography imaging of regional cerebral glucose metabolism.

A. Alavi, M. Reivich, R. Dann, 1986, Seminars in nuclear medicine.

Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.

F Fazekas, A. Alavi, M. Reivich, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comprehensive Long-Term Follow-up

S. Palmer, A. DeMichele, D. Vaughn, 2007 .

Effects of radiation therapy on adult brain behavior

M. Grossman, B. Corn, J. Alavi, 1993, Neurology.

New grading system of cerebral gliomas using positron emisson tomography with F-18 fluorodeoxyglucose

A. Alavi, M. Reivich, J. Alavi, 1991, Journal of Neuro-Oncology.

Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study.

A. Alavi, F. Bénard, J. Alavi, 1998, American journal of clinical oncology.

Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy.

A. Alavi, A. Newberg, J. Alavi, 2000, Clinical nuclear medicine.

Complementary roles of PET and MR spectroscopy in the management of brain tumors.

A. Alavi, R. Lenkinski, J. Alavi, 1990, Radiology.

Multiple Intraabdominal Soft-Tissue Masses in a Man Awaiting Liver Transplantation: A Case Study and Discussion

A. Alavi, S. Stein, H. Zhuang, 2000, American journal of clinical oncology.

Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.

J. Alavi, W. Wegener, A. Alavi, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

fﬁ d f h Efﬁ cacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C- (cid:1) delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas 1,2

J. Holmlund, J. Supko, K. Carson, 2004 .

Sickle cell anemia. Pathophysiology and treatment.

J. Alavi, 1984, The Medical clinics of North America.

Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.

A. Alavi, D. Hackney, K. Propert, 2001, Human gene therapy.

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

A. Alavi, D. Hackney, K. Judy, 1996, Human gene therapy.

Phase II Trial of Spirogermanium and Vindesine in Malignant Glioma

D. Schoenfeld, J. Alavi, J. Marsh, 1989, American journal of clinical oncology.

Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.

T. Mikkelsen, S. Brem, S. Phuphanich, 2005, Neuro-oncology.

Phase 2 trial of copper depletion and penicillamine as antiangiogenesis

T. Mikkelsen, S. Brem, K. Carson, 2005 .

Aplastic anemia associated with intravenous chloramphenicol

J. Alavi, 1983, American journal of hematology.

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

T. Batchelor, K. Carson, S. Grossman, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene therapy for malignant gliomas.

J. Alavi, S. Eck, 1998, Hematology/oncology clinics of North America.

Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): The Expanded Access Protocol Experience at the University of Pennsylvania

J. Shults, J. Stevenson, M. L. Veronese, 2005, Cancer investigation.

Hypertension with renal carcinoma an effect of arterial embolization

J. Alavi, G. Mclean, 2006, Cancer.

Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme

T. Mikkelsen, S. Rosenfeld, K. Carson, 2007, Investigational New Drugs.

Late recurrence of primitive neuroectodermal Tumor/Medulloblastoma

L. Rorke, R. Packer, J. Alavi, 1988, Cancer.

Utility of F-FDG PET/CT in pre-surgical risk stratification of patients with breast cancer

T. Werner, A. Alavi, J. Alavi, 2019 .

Gene therapy for high grade gliomas

J. Alavi, J B Alavi, S L Eck, 2001, Expert opinion on biological therapy.

Positron emission tomography in patients with glioma a predictor of prognosis

Abass Alavi, Martin Reivich, John Powe, 1988, Cancer.

Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.

J. Holmlund, J. Supko, K. Carson, 2005, Neuro-oncology.

Treatment o f P rimary C NS L ymphoma W ith M ethotrexate a nd Deferred R adiotherapy: A R eport o f N ABTT 9 6 - 0 7

T. Batchelor, K. Carson, S. Grossman, 2003 .

Multi‐institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high‐grade gliomas

S. Pannullo, R. Fine, P. Fisher, 2008, Cancer.

Correlative Studies of the Brain with Positron Emission Tomography, Nuclear Magnetic Resonance, and X-Ray Computed Tomography

A. Alavi, M. Reivich, W. Edelstein, 1985 .

PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.

A. Alavi, C. Buchpiguel, J. Alavi, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The Effect of Enzyme-Inducing Antiseizure Drugs on the Pharmacokinetics and Tolerability of Procarbazine Hydrochloride

T. Mikkelsen, S. Phuphanich, T. Batchelor, 2006, Clinical Cancer Research.

Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma.

A. Alavi, M. Reivich, R. Dann, 1987, Nuclear medicine communications.

Cerebral Metabolic Changes in Patients with Brain Tumors Demonstrated by Positron Emission Tomography

A. Alavi, M. Reivich, D. Hackney, 1992 .

Labeled cells in the investigation of hematologic disorders.

J. Alavi, J. Hansell, J. Alavi, 1984, Seminars in nuclear medicine.

Evaluation of response to gene therapy for malignant gliomas with FDG PET imaging and MRI

A. Alavi, R. Hustinx, F. Bénard, 1998 .